Latest news
Loading news…
Intellikine
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring). La Jolla, California, United States Founded 2007 51-100 employees For Profit
Intellikine is focused on the R&D of orally available small molecule drugs targeting the PI3K/mTOR pathway.
Intellikine was acquired by Takeda in 2011 for $310M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
2
Patents
15
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 60
- Active products
- 3
- Patents granted
- 15
- Trademarks
- 0
- Top patent class
- Medical Or Veterinary Science; Hygiene
- IT spend
- $9M
Company Info
- Founded
- 2007
- Employees
- 51-100
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 18
- HQ
- La Jolla, California, United States
- Region
- Greater San Diego Area, West Coast, Western US
- Exit date
- Dec 21, 2011
- Closed
- Aug 8, 2012
Signals & Scores
- Heat score
- Low
- Trend (7d)
- 0.9
- Trend (30d)
- 6.1
- Trend (90d)
- 4.4
2
professional contacts at Intellikine
Contact execs at Intellikine →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Intellikine
Loading news…
FAQs about Intellikine
People who checked this page also checked these
Browse the full Acquirezy directory.